US EditionFDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva’s New Jersey site – Pennsylvania NY NJ Biotech Networks
Summary by Los Angeles Biotechnology Network
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva's New Jersey site - Los Angeles Biotechnology Network
An FDA inspection report on Teva’s manufacturing site in New Jersey has revealed issues with both equipment cleaning and quality. The three-page report, which was obtained by Endpoints News via a FOIA request from the FDA, showed several observations f... [...]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
